Pfaff J, Pham M, Herweh C, Wolf M, Ringleb P A, Schönenberger S, Bendszus M, Möhlenbruch M
Department of Neuroradiology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Clin Neuroradiol. 2017 Jun;27(2):185-192. doi: 10.1007/s00062-015-0463-2. Epub 2015 Sep 2.
Stroke networks have been installed to increase access to advanced stroke specific treatments like mechanical thrombectomy (MT). This concept often requires patients to be transferred to a comprehensive stroke center (CSC) offering MT. Do patient referral, transportation, and logistic effort translate into clinical outcomes comparable to patients admitted primarily to the CSC?
We categorized 112 patients with acute ischemic stroke in the anterior circulation, who received MT at our institution, into primary admissions (A) and referrals from either local (B) or regional (C) hospitals, assessed the clinical outcome, and tested the impact of distance and delay of transportation from the referring remote hospital.
The median time from symptom onset to initial CT was similar in all groups (p = 0,939). Patients who were transferred to the CSC had significantly increasing median time between initial CT and MT (in minutes (interquartile range [IQR]); A: 83 [68-120]; B: 174 [159-208]; C: 220 [181-235]; p < 0.001) and median time between onset to MT (in minutes [IQR]; A: 178 [150-210]; B: 274 [238-349]; C: 293 [256-329]; p < 0.001). After 90 days of MT there was no significant difference in clinical outcome (modified Rankin Scale ≤ 2) between primary admitted and referred patients (p = 0.502).
Clinical outcome in patients who received MT after transfer from either local or regional remote hospitals was not significantly worse than in patients primarily admitted to the CSC. In the event of an acute ischemic stroke patients living in urban or rural areas should, despite a possible delay, have access to MT.
已建立卒中网络以增加获得机械取栓术(MT)等高级卒中特异性治疗的机会。这一概念通常要求将患者转运至提供MT的综合卒中中心(CSC)。患者的转诊、运输和后勤工作能否转化为与主要入住CSC的患者相当的临床结局?
我们将在我院接受MT治疗的112例急性前循环缺血性卒中患者分为直接入院组(A)以及来自当地(B)或区域(C)医院的转诊组,评估临床结局,并测试转诊的偏远医院的距离和运输延迟的影响。
所有组从症状发作到首次CT的中位时间相似(p = 0.939)。转入CSC的患者在首次CT与MT之间的中位时间(以分钟计[四分位间距(IQR)];A组:83 [68 - 120];B组:174 [159 - 208];C组:220 [181 - 235];p < 0.001)以及从发作到MT的中位时间(以分钟计[IQR];A组:178 [150 - 210];B组:274 [238 - 349];C组:293 [256 - 329];p < 0.001)显著增加。MT治疗90天后,直接入院患者和转诊患者的临床结局(改良Rankin量表≤2)无显著差异(p = 0.502)。
从当地或区域偏远医院转诊后接受MT治疗的患者的临床结局并不比主要入住CSC的患者明显更差。对于急性缺血性卒中患者,无论居住在城市还是农村,即使可能有延迟,也应能获得MT治疗。